1,3-diphenylpropane
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Ryu, Jae-Ha:
2 articles
(01/2022 - 01/2015)
|
| 2. | Jeong, Ji Hye:
1 article
(01/2022)
|
| 3. | Kim, Keun Il:
1 article
(01/2022)
|
| 4. | Kwon, Junhee:
1 article
(01/2022)
|
| 5. | Lee, Yunkyeong:
1 article
(01/2022)
|
| 6. | Kim, Hak-Su:
1 article
(01/2015)
|
| 7. | Lee, Da Yeon:
1 article
(01/2015)
|
| 8. | Lim, Jihyun:
1 article
(01/2015)
|
| 9. | Lim, Jong-Seok:
1 article
(01/2015)
|
| 10. | Fujimoto, Nariaki:
1 article
(03/2003)
|
Related Diseases
| 1. | Edema (Dropsy)
|
| 2. | Colonic Neoplasms (Colon Cancer)
|
| 3. | Breast Neoplasms (Breast Cancer)
03/01/2003
- " Trans-1,2-diphenylcyclobutane (TCB), cis-1,2-diphenylcyclobutane (CCB), 1,3-diphenylpropane, 2,4-diphenyl-1-butene, 2,4,6-triphenyl-1-hexene, and 1-alpha-phenyl-4ss-(1 -phenylethyl)tetralin were negative in the yeast estrogen screening assay and estrogen reporter assay using estrogen-responsive human breast cancer cell line MCF-7. "
|
|
Related Drugs and Biologics
Related Therapies and Procedures